Literature DB >> 16389480

In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil.

R A Cordeiro1, R S N Brilhante, M F G Rocha, M A B Fechine, A K F Costa, Z P Camargo, J J C Sidrim.   

Abstract

Coccidioidomycosis is a systemic infection caused by the soil-dwelling dimorphic fungi Coccidioides spp. The disease is endemic in semiarid Northeast Brazil, where it is caused by C. posadasii. The aim of this study was to perform antifungal susceptibility tests of clinical and environmental strains of C. posadasii from Northeast Brazil. The in vitro activities of caspofungin, amphotericin B and azoles against clinical and environment isolates of C. posadasii were determined in accordance with the NCLLS M-38P macrodilution method. The antifungal susceptibility analysis showed that all the strains of C. posadasii (n = 10) were sensitive to caspofungin (16 microg/ml < or = MIC < or = 32 microg/ml), amphotericin B (0.0625 mug/ml < or = MIC < or = 0.125 microg/ml), ketoconazole (0.039 microg/ml < or = MIC < or = 0.156 microg/ml), itraconazole (0.125 microg/ml < or = MIC < or = 0.5 microg/ml), fluconazole (3.125 microg/ml < or = MIC < or = 6.25 microg/ml), and voriconazole (0.125 microg/ml). This study is the first description of in vitro antifungal susceptibility pattern of Brazilian strains of C. posadasii.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16389480     DOI: 10.1007/s11046-005-0177-0

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  20 in total

1.  Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.

Authors:  G M González; R Tijerina; L K Najvar; R Bocanegra; M Luther; M G Rinaldi; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America.

Authors:  J N Galgiani; N M Ampel; A Catanzaro; R H Johnson; D A Stevens; P L Williams
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

3.  Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.

Authors:  D Pappagianis; B L Zimmer; G Theodoropoulos; M Plempel; R F Hector
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis.

Authors:  J E Lutz; K V Clemons; B H Aristizabal; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  Quality control limits for broth microdilution susceptibility tests of ten antifungal agents.

Authors:  A L Barry; M A Pfaller; S D Brown; A Espinel-Ingroff; M A Ghannoum; C Knapp; R P Rennie; J H Rex; M G Rinaldi
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

6.  In vitro and in vivo activities of posaconazole against Coccidioides immitis.

Authors:  Gloria M González; Rolando Tijerina; Laura K Najvar; Rosie Bocanegra; Michael Rinaldi; David Loebenberg; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 7.  Coccidioidomycosis in solid organ transplantation.

Authors:  J E Blair; J L Logan
Journal:  Clin Infect Dis       Date:  2001-10-04       Impact factor: 9.079

Review 8.  Coccidioidomycosis: efficacy of new agents and future prospects.

Authors:  S C Deresinski
Journal:  Curr Opin Infect Dis       Date:  2001-12       Impact factor: 4.915

Review 9.  Influence of host genetics on the severity of coccidioidomycosis.

Authors:  L Louie; S Ng; R Hajjeh; R Johnson; D Vugia; S B Werner; R Talbot; W Klitz
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

10.  In vitro antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms.

Authors:  Toru Nakai; Jun Uno; Fumiaki Ikeda; Shuichi Tawara; Kazuko Nishimura; Makoto Miyaji
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

View more
  4 in total

1.  Antifungal therapeutics for dimorphic fungal pathogens.

Authors:  Kristie D Goughenour; Chad A Rappleye
Journal:  Virulence       Date:  2016-09-19       Impact factor: 5.882

2.  Large-Scale Evaluation of In Vitro Amphotericin B, Triazole, and Echinocandin Activity against Coccidioides Species from U.S. Institutions.

Authors:  George R Thompson; Bridget M Barker; Nathan P Wiederhold
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

3.  Effect of farnesol on growth, ergosterol biosynthesis, and cell permeability in Coccidioides posadasii.

Authors:  Raimunda Sâmia Nogueira Brilhante; Rita Amanda Chaves de Lima; Erica Pacheco Caetano; João Jaime Giffoni Leite; Débora de Souza Collares Maia Castelo-Branco; Joyce Fonteles Ribeiro; Tereza de Jesus Pinheiro Gomes Bandeira; Rossana de Aguiar Cordeiro; André Jalles Monteiro; José Júlio Costa Sidrim; Marcos Fábio Gadelha Rocha
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

4.  Antifungal susceptibility profiles of Coccidioides immitis and Coccidioides posadasii from endemic and non-endemic areas.

Authors:  Rama Ramani; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2007-05-07       Impact factor: 3.785

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.